Scientists use blood test to predict who is likely to develop psychotic disorders

blood sample
Credit: CC0 Public Domain

Scientists have discovered that testing the levels of certain proteins in blood samples can predict whether a person at risk of psychosis is likely to develop a psychotic disorder years later.

The study is published in the current edition of JAMA Psychiatry and was led by researchers from RCSI University of Medicine and Health Sciences.

Based on certain criteria, such as mild or brief psychotic symptoms, some people are considered to be clinically at high risk of developing a psychotic disorder, such as schizophrenia. However, only 20% to 30% of these people will actually go on to develop a psychotic disorder.

The researchers analyzed taken from people at clinical high risk of psychosis. These individuals were followed up for several years to see who did and did not develop a psychotic disorder.

After assessing the proteins in blood samples and using machine learning to analyze this data, the scientists were able to find patterns of proteins in the early blood samples that could predict who did and did not develop a psychotic disorder at follow-up.

Many of these proteins are involved in inflammation, suggesting that there are early changes in the in people who go on to develop a psychotic disorder. The findings also suggest that it is possible to predict their outcomes using blood samples taken several years in advance.

The most accurate test was based on the 10 most predictive proteins. It correctly identified those who would go on to develop a psychotic disorder in 93% of high-risk cases, and it correctly identified those who would not in 80% of cases.

"Ideally, we would like to prevent psychotic , but that requires being able to accurately identify who is most at risk," said Professor David Cotter, the study's senior and corresponding author and professor of molecular psychiatry at RCSI.

"Our research has shown that, with help from , analysis of levels in samples can predict who is at truly at risk and could possibly benefit from preventive treatments. We now need to study these markers in other people at high risk of psychosis to confirm these findings."

A has been filed, and the research team is working to commercialize this research through licensing or partnering with industry.


Explore further

Targeted treatment for depression could benefit patients with psychosis

More information: David Mongan et al, Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence, JAMA Psychiatry (2020). DOI: 10.1001/jamapsychiatry.2020.2459
Journal information: JAMA Psychiatry

Provided by RCSI
Citation: Scientists use blood test to predict who is likely to develop psychotic disorders (2020, August 26) retrieved 19 September 2021 from https://medicalxpress.com/news/2020-08-scientists-blood-psychotic-disorders.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
25 shares

Feedback to editors